Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00066378 | Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer | completed | Phase 2 | 71 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Oct 24, 2013 | clinicaltrials |
| NCT01281696 | Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal Metastasis | completed | Phase 2 | 40 | National Taiwan University HospitalOTHER | 1 |
| Oct 16, 2013 |
| clinicaltrials |
| NCT00527930 | Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast Cancer(TORCH) | completed | Phase 2 | 87 | Seoul National University HospitalOTHER | 1 | Oct 10, 2013 | clinicaltrials |
| NCT00043017 | Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer(ACRIN 6657) | completed | Phase 2 | 356 | American College of Radiology Imaging NetworkNETWORK | 1 | Oct 9, 2013 | clinicaltrials |
| NCT00006228 | Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00526149 | BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | completed | Phase 2 | 76 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Oct 7, 2013 | clinicaltrials |
| NCT00392392 | Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer | completed | Phase 2 | 29 | SCRI Development Innovations, LLCOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT01038804 | A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer | completed | Phase 2 | 101 | Astellas Pharma IncINDUSTRY | 8 | Sep 18, 2013 | clinicaltrials |
| NCT01338753 | Study to Evaluate Markers of Response in Locally Advanced Breast Cancer(IMAGING) | completed | Phase 2 | 74 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Sep 10, 2013 | clinicaltrials |
| NCT00104702 | Radiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast Cancer(GERICO03) | completed | Phase 2 | 46 | UNICANCEROTHER | 1 | Sep 4, 2013 | clinicaltrials |
| NCT00424203 | Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery | completed | Phase 2 | 40 | UNICANCEROTHER | 1 | Sep 4, 2013 | clinicaltrials |
| NCT01554943 | Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients | completed | Phase 2 | 73 | Jules Bordet InstituteOTHER | 1 | Aug 30, 2013 | clinicaltrials |
| NCT00266331 | RayGel-An Alternative for Skin Care During External Beam Radiation | completed | Phase 2 | 150 | Nathalie JohnsonOTHER | 1 | Aug 28, 2013 | clinicaltrials |
| NCT00321633 | Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer | completed | Phase 2 | 148 | University College London HospitalsOTHER | 6 | Aug 26, 2013 | clinicaltrials |
| NCT00005635 | Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 | completed | Phase 2 | — | Genentech, Inc.INDUSTRY | 1 | Aug 20, 2013 | clinicaltrials |
| NCT00965523 | Study of E7389 for Advanced or Metastatic Breast Cancer | completed | Phase 2 | 81 | Eisai Co., Ltd.INDUSTRY | 1 | Aug 15, 2013 | clinicaltrials |
| NCT00242203 | Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer | completed | Phase 2 | 120 | Washington University School of MedicineOTHER | 1 | Aug 13, 2013 | clinicaltrials |
| NCT00284180 | Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer | completed | Phase 2 | 32 | SCRI Development Innovations, LLCOTHER | 1 | Aug 9, 2013 | clinicaltrials |
| NCT00978770 | MRI in Predicting Early Response to Chemotherapy in Patients With Locally Advanced Breast Cancer | completed | Phase 2 | 50 | Cancer Clinical Trials Unit, ScotlandOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00193037 | Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer | completed | Phase 2 | 102 | SCRI Development Innovations, LLCOTHER | 1 | Jul 31, 2013 | clinicaltrials |
| NCT01380808 | Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC) | completed | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Jul 26, 2013 | clinicaltrials |
| NCT00574301 | Percutaneous Removal and Margin Ablation for Breast Cancer | completed | Phase 1 / Phase 2 | 32 | University of ArkansasOTHER | 1 | Jul 25, 2013 | clinicaltrials |
| NCT00002680 | Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer | completed | Phase 2 | 40 | Yale UniversityOTHER | 1 | Jul 24, 2013 | clinicaltrials |
| NCT01387841 | Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting | completed | Phase 2 | 120 | Bharath Charitable Cancer Hospital and InstituteOTHER | 1 | Jul 24, 2013 | clinicaltrials |
| NCT00320541 | A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer | completed | Phase 2 | 187 | Eli Lilly and CompanyINDUSTRY | 2 | Jul 22, 2013 | clinicaltrials |
| NCT00002873 | Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer | completed | Phase 1 / Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Jul 19, 2013 | clinicaltrials |
| NCT00107276 | S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer | completed | Phase 2 | 112 | SWOG Cancer Research NetworkNETWORK | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00546104 | Phase II Dasatinib Study in Advanced Breast Cancer | completed | Phase 2 | 31 | Duke UniversityOTHER | 1 | Jul 17, 2013 | clinicaltrials |
| NCT00002475 | Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | completed | Phase 2 | 40 | St. Vincent Medical Center - Los AngelesOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00107393 | Trastuzumab and Capecitabine in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 75 | Tohoku UniversityOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00003540 | Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and Paclitaxel | completed | Phase 2 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003428 | Hormone Therapy in Treating Women With Breast Cancer | completed | Phase 2 | 114 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00003539 | Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer | completed | Phase 2 | 50 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00354640 | Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer | completed | Phase 2 | 11 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00019084 | Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019500 | Raloxifene in Preventing Breast Cancer in Premenopausal Women | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019916 | Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00020176 | Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00045097 | Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00004925 | Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00030537 | Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00052351 | Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00052728 | Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00020904 | BMS-247550 in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00020332 | Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00027885 | Phase II Bevacizumab + Tax In Advanced Breast Cancer | completed | Phase 2 | 49 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 17, 2013 | clinicaltrials |
| NCT01537536 | Trial of Neoadjuvant EndoTAG-1 in Combination With Paclitaxel in HER2-negative Breast Cancer(EndoTAG-1) | completed | Phase 2 | 18 | Jules Bordet InstituteOTHER | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00041067 | S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer | completed | Phase 2 | 76 | SWOG Cancer Research NetworkNETWORK | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00049114 | Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer | completed | Phase 2 | 62 | National Cancer Institute (NCI)NIH | 1 | Jun 6, 2013 | clinicaltrials |
Data updated 24 days agoSource updated Oct 24, 2013source: clinicaltrials